Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1GLC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,635
Award facts
- Contract value 100% obligated
- $42,635.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 28, 2026, to AmerisourceBergen Drug Corp (a subsidiary of parent company Cencora, Inc.) by the Defense Logistics Agency, provides for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. The contract is firm fixed-price with a ceiling value of approximately $42.6k and an ultimate completion date of January 29, 2026. This award represents a competitive procurement with no set-aside designation, leveraging the company's established pharmaceutical distribution capabilities to support federal medical supply needs.
This delivery order is executed under Cencora's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at up to $1 billion through December 2031. The parent IDC provides a comprehensive vehicle for delivering pharmaceutical products, medical supplies, specialty medications, generic drugs, vaccines, and related medical commodities to support military healthcare programs globally, including Defense Health Agency facilities, U.S. Coast Guard operations, and other government healthcare systems. AmerisourceBergen's subsidiary maintains its corporate office in Conshohocken, Pennsylvania, and continues to serve as a critical vendor in the federal pharmaceutical supply chain through both this major contract vehicle and multiple individual task orders supporting the Department of Defense medical infrastructure.
Quick answers
Who was awarded contract SPE2DR26F1GLC?
SPE2DR26F1GLC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F1GLC worth?
The government has obligated $42,635 on SPE2DR26F1GLC.
Is contract SPE2DR26F1GLC an order under another contract?
Yes. SPE2DR26F1GLC is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1GLC competed?
The extent of competition for SPE2DR26F1GLC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award